Navigation Links
Acridinium C2 NHS Ester from Assay Designs/Stressgen Bioreagents

ProductsAcridinium C2 NHS Ester from Assay Designs/Stressgen Bioreagents
Company Assay Designs/Stressgen Bioreagents
Item Acridinium C2 NHS Ester
Price $350.00
Description Acridinium esters have moderate chemiluminescence efficiencies and the chemistry of light production is well understood. They have the added benefit that they require simple triggering conditions that contribute little to the background signal. This benefit has been exploited to great effect in high sensitivity immunoassay applications. These compounds can also be easily modified to attach to proteins and other molecules of interest, without significantly affecting their chemiluminescence properties.
  • Simple NHS Chemistry
  • Direct, High Specific Activity Chemiluminescent Label
  • Labels Any Primary Amine Group
  • Can Be Read in Most Plate or Tube Luminometers
Info Assay Designs/Stressgen BioreagentsAssay Designs/Stressgen Bioreagents
5777 Hines Drive
Ann Arbor, MI 48108

Customer Service: (800) 833-8651
Fax Number: (734) 668-2793
Web Site: http://www.assaydesigns.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Acridinium NHS ester from Cayman Chemical
2. Acridinium NHS ester from Cayman Chemical
3. Acridinium Purification Buffer (10X) from Cayman Chemical
4. Acridinium Labeling Buffer from Cayman Chemical
5. Acridinium Ester Trigger Solutions from Assay Designs/Stressgen Bioreagents
6. Acridinium Quench Solution from Cayman Chemical
7. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
8. In Vitro Osteogenesis Assay Kit from CHEMICON
9. Mast Cell Degranulation colorimetric Assay Kit from CHEMICON
10. PR Competitor Assay Green from Invitrogen
11. PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
...
... Modification Services ,,GenScript offers many ... and antibody fragmentation. Labeling antibodies with ... visualization and quantitation of the target ... preferable to use only the antigen-binding ...
... WesternBreeze Immunodetection Kits are designed ... immobilized on nitrocellulose or PVDF membranes. ... (except membranes and primary antibodies), the ... both optimizing your protocol and getting ...
Request Info...
Biology Products:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... Georgia (PRWEB) , ... October 11, 2017 , ... Disappearing ... taking the lives of over 5.5 million people each year. Especially those living in ... greenovative startup Treepex - based in one of the most pollution-affected countries globally - ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
Breaking Biology Technology: